Results 251 to 260 of about 80,395 (343)

Understanding lipidomics associations and the lipoprotein-related caveats in population epidemiology. [PDF]

Am J Epidemiol
Zhao S, Ohukainen P, Kettunen J, Järvelin MR, Kähönen M, Lehtimäki T, Viikari J, Raitakari OT, Mäkinen VP, Ala-Korpela M.   +9 more
europepmc   +1 more source

Regulated Cell Death in Idiopathic Pulmonary Fibrosis

The FASEB Journal, Volume 40, Issue 9, 15 May 2026.
This graphical abstract illustrates regulated cell death (RCD) across key pulmonary cell types—including alveolar epithelial cells, fibroblasts, macrophages, and endothelial cells—modulated through a dynamic death modulation network within the IPF microenvironment.
Xiaoyue Pan, Liu Yang, Man Zhao, Yanlin Zhou, Cong Xia, Huibing Liu, Yuqi Wang, Hui Lian, Bin Li, Lan Wang, Guoying Yu   +10 more
wiley   +1 more source

A vegan diet signature from a multi-omics study on different European populations is related to favorable metabolic outcomes. [PDF]

Gut Microbes
Ouradova A, Ferrero G, Bratova M, Daskova N, Bohdanecka A, Dohnalova K, Heczkova M, Chalupsky K, Kralova M, Kuzma M, Modos I, Tichanek F, Najmanova L, Pardini B, Pelantová H, Tarallo S, Videnska P, Gojda J, Naccarati A, Cahova M.   +19 more
europepmc   +1 more source

Apolipoprotein A‐I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review

Clinical Cardiology, Volume 49, Issue 5, May 2026.
Apolipoprotein A‐I (ApoA‐I), the principal protein of HDL, plays a key role in reverse cholesterol transport, inflammation modulation, and plaque stabilization in atherosclerotic cardiovascular disease. Emerging ApoA‐I–based therapies, including CSL112, enhance cholesterol efflux capacity, though definitive reductions in cardiovascular events remain ...
Awais Habib, Muhammad Saood Moazzam Khan, Ahmad Aneeq, Hafiz Muhammad Talha Tahir, Amin Mehmoodi, Jahanzeb Malik, Abida Perveen   +6 more
wiley   +1 more source

Lipidomic signatures in maternal blood and placenta: Systematic evidence linking lipid profiles to pregnancy outcomes and fetal growth. [PDF]

Metabol Open
Kalapouti E, Bothou A, Harizopoulou V, Vlachou M, Vasiliki Zampeli M, Diamanti A.   +5 more
europepmc   +1 more source

Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This review synthesises current knowledge on gut microbiome involvement in obesity and hypertension, evaluates microbiome‐based therapeutic strategies, and identifies critical research gaps to guide future investigations aimed at mitigating the dual pandemics.
Andrej Belančić, Almir Fajkić, Yusuf Ziya Sener, Ana Jelaković, Lejla Alić, Elvira Meni Maria Gkrinia, Donatella Verbanac, Bojan Jelaković   +7 more
wiley   +1 more source

Lipidomic Analysis of Human Plasma and Hippocampus Across Alzheimer's Progression and Preclinical 5xFAD Mouse Model. [PDF]

Mol Neurobiol
Castroflorio E, Cabot J, Miralles M, Suau-Fullana M, Peter M, Balogh G, Torok Z, Rodríguez E, Sanchez-Juan P, Férnandez-García P, Llado V, Escribá PV, Torres M.   +12 more
europepmc   +1 more source

Lipoprotein Metabolism in the Suckling Rat - Characterization of Plasma and Lymphatic Lipoproteins [PDF]

, 1983
Clark, WA, Eckerson, ML, Fernandowarnakulasuriya, Gjp, Wells, MA   +3 more
core